$PED

PEDEVCO CORP (PED): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

PEDEVCO CORP (PED) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.7 3 ped_ex107.htm EMPLOYMENT AGREEMENT ped_ex107.htm EXHIBIT 10.7 EMPLOYMENT AGREEMENT This Employment Agreement (the “ Agreement ”), dated July 21, 2026 (the “ Effective Date ”), is entered into by and between Robert J. Long (“ Executive ”) and PEDEVCO Corp., a Texas corpo

Original reporting
Published Jul 24, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 9:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$PED
Neutral
medium confidence
Mentioned
$PED
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PEDNeutralLow
01

Why it matters

This is a governance and compensation disclosure. It may affect investor perception of leadership continuity, but the excerpt provides no new operating metrics, guidance, or material transaction.

02

Market read

For PED, the actionable takeaway is the CFO appointment and compensation framework, with no disclosed immediate financial catalyst.

03

What to watch

The agreement includes change-in-control and termination benefit mechanics; traders may want to check whether this CFO hire coincides with broader corporate actions not shown in the excerpt.

Relevance 6/10Novelty 4/10Timing: Filed after-hours on 2026-07-24, effective July 21, 2026 for CFO employment terms.

Background

The SEC 8-K (Item 5.02) reports an employment agreement for a newly appointed CFO, including base salary, bonus eligibility, equity award eligibility, and termination/change-in-control provisions.

Company-level read

Ticker impact

$PEDNeutralMedium confidence
Context

PEDEVCO’s 8-K discloses a new July 21, 2026 employment agreement appointing Robert J. Long as CFO with defined pay and bonus terms.

Expected impact

Likely low immediate price impact; any reaction would be sentiment-driven around leadership stability rather than earnings power.

Evidence & confidence

The newest concrete facts are CFO appointment and compensation structure (salary $280k, target bonus 50%), not financial results, guidance, or a transaction.

Market effects

Minimal sector read-through; this is company-specific executive compensation and role assignment.

No clear regional market linkage beyond Houston-based operations mentioned in the agreement.

None; the disclosure is localized to PEDEVCO’s corporate governance.

Counterpoint

Even without new financial guidance, a CFO appointment can signal internal restructuring or a shift in financial reporting priorities, which could matter if paired with other undisclosed changes.

Key entities

  • PEDEVCO Corp.

    Subject of the SEC 8-K, reporting the CFO employment agreement and related compensatory arrangements.

  • Robert J. Long

    Executive entering the employment agreement to serve as Chief Financial Officer.

Related articles

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.

$MTZMed

Is MasTec’s Debt Raise and Upgraded Guidance Altering The Investment Case For MasTec (MTZ)?

MasTec (MTZ) completed a $647.76 million fixed-rate senior unsecured notes offering with a 5.85% coupon due Sept. 30, 2036. The company reported Q2 2026 sales of $4,373.55 million and net income of $130.12 million, and raised full-year 2026 revenue guidance to $18.2 billion and GAAP net income to $539 million, citing balance-sheet flexibility and governance updates.